ArticleCommunications medicine2024

Casirivimab-imdevimab monoclonal antibody treatment for an immunocompromised patient with persistent SARS-CoV-2 infection: a case report.

Karun Saathveeg Sam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.